Effect superoxide dismutase infarct size postischemic recovery myocardial contractility metabolism dogs effects superoxide dismutase treatment infarct size postischemic recovery contractile function tissue content high energy phosphates canine model myocardial ischemia reperfusion Ischemia thrombotic occlusion coronary artery reperfusion intravenous thrombolysis Average duration ischemia min Fifty anesthetized dogs superoxide dismutase IU/min placebo min min reperfusion phase Left ventricular ejection fraction regional segmental shortening postischemic area contrast angiograms week reperfusion Tissue content high energy phosphates transmural biopsy week Infarct size planimetry dye-stained heart slices superoxide dismutase placebo-treated groups mortality rate collateral flow ml/min area risk left ventricle infarct size area risk Multiple regression analysis beneficial effect superoxide dismutase treatment infarct size Left ventricular ejection fraction regional segmental shortening postischemic area tissue content high energy phosphates similar extent similar rate treated placebo groups week reperfusion model coronary occlusion reperfusion superoxide dismutase treatment benefit 